Day One Biopharmaceuticals, Inc.
DAWN
$21.31
$0.020.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.38% | -80.04% | 43.28% | 66.94% | 49.45% |
| Total Depreciation and Amortization | 86.59% | 158.63% | 363.22% | 584.63% | 429.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 358.14% | 387.84% | 235.98% | -139.89% | -134.49% |
| Change in Net Operating Assets | -209.30% | -113.79% | -209.98% | -329.00% | 181.16% |
| Cash from Operations | -32.83% | -33.68% | 64.43% | 48.78% | 46.81% |
| Capital Expenditure | 85.25% | -129.42% | -3,184.00% | -1,155.56% | -868.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 176.45% | -473.67% | -251.16% | -252.98% | -277.93% |
| Cash from Investing | 175.61% | -480.25% | -252.29% | -254.20% | -279.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.33% | -98.56% | 8,735.83% | 11.94% | 11.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -99.40% | -98.71% | 9,753.86% | 24.80% | 23.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 168.15% | -308.99% | -504.71% | -207.20% | -172.71% |